ABSI Stock Analysis: Buy, Sell, or Hold?
ABSI - Absci Corporation Common Stock
$8.32
0.16 (1.96%)
▲
5d:
-18.67%
30d:
+12.28%
90d:
+110.63%
WAIT
LOW Confidence
Analysis Updated: Jul 21, 2026 12:00 AM ET
Earnings: Aug 11, 2026
20d
Smart Money Accumulation
None View Scanner →
Strength: 5.5/10
Get Alerted When ABSI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: ABSI is down 18.7% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: ABSI is down 18.7% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: ABSI is currently trading at $8.32, which is considered slightly low relative to its 30-day fair value range of $7.83 to $11.21.
Technical Outlook: Technically, ABSI is in a strong uptrend. Immediate support is located at $7.58, while resistance sits at $12.00.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $13.78 (+65.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ABSI is in a strong uptrend. Immediate support is located at $7.58, while resistance sits at $12.00.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $13.78 (+65.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$7.83 -
$11.21
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 65.6% below Wall St target ($13.78)
- WARNING: Recommendation downgraded due to -18.7% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$7.83 -
$11.21
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$7.58
Resistance Level
$12.00
Current Trend
Strong Uptrend
Technical data as of
Jul 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-13.37
Wall Street Target
$13.78
(+65.6%)
Revenue Growth (YoY)
-81.8%
Share & Embed Analysis
Last updated: July 21, 2026 5:45 PM ET
Data refreshes hourly during market hours. Next update: 6:45 PM
Data refreshes hourly during market hours. Next update: 6:45 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ABSI showing a specific setup today?
Insider Activity (6 Months)
1
Buys
1
Sells
0
Net
NEUTRAL
Recent Transactions
Andreas Busch
BUY
100000 shares
2026-03-12
Sean Mcclain
SELL
26761 shares
2026-02-02
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$26 | 51 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$819 | 57 HOLD |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$56 | 50 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$262 | 55 HOLD |
|
CNTA
Centessa Pharmaceuticals… |
STRONG BUY
11 analysts |
$44 | 61 BUY |
